AGC to produce British immunotherapy at Danish facility
British biotech company Essential Pharma has hired contract manufacturer AGC Biologics to produce a potential treatment for neuroblastoma, the most common cancer outside the brain in children.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
AGC Biologics expands contract manufacturing in Italy
For subscribers
Plans for Copenhagen's Innovation District revealed
For subscribers